Seroquel MDL Judge Upholds Ban On Foreign Evidence
AstraZeneca LP has prevailed in its battle to keep out evidence of overseas regulatory actions from upcoming trials in multidistrict U.S. litigation over the drugmaker's blockbuster anti-psychotic medication Seroquel....To view the full article, register now.
Already a subscriber? Click here to view full article